"In our study, we showed that fine needle aspiration (FNA) biopsy material can be a good source for next-generation sequencing (NGS) for patients with metastatic prostate cancer. Based on these ...

Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...

Delays in time to first lenalidomide prescription fill for multiple myeloma. Preliminary results of a combined home and rural outpatient clinic-based infusion program through the Veterans Health ...

Attitudes and knowledge towards breast cancer among non-healthcare workers at an educational institution. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract does ...

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...

Peter Fromen, CEO of biomodal, said: "We designed our technology to be platform agnostic to ensure researchers have access to the highest quality multiomic data. Through this partnership with Element, ...

Fill out the form below and we'll send your colleague an invitation to the "Improving Sequencing Performance Through Optimized Library Prep Enzymes" event. As next-generation sequencing (NGS) ...